False Scientifically refuted Certainty of evidence: high provisional C-SUG-07

Advice given live to a viewer: stop insulin, it is not needed; eat sugar normally.

Safety note: Do not stop or reduce insulin without your treating physician. Stopping insulin in insulin-dependent diabetes (all type 1 and many type 2) can cause diabetic ketoacidosis, which is a medical emergency and can be fatal. No diet, including eating sugar 'normally', replaces insulin in type 1 diabetes. High blood glucose with ketones, vomiting or breathlessness requires urgent medical care.

In short: This claim is false and dangerous. Stopping insulin in insulin-dependent diabetes can cause diabetic ketoacidosis, which is a leading and potentially fatal consequence of insulin omission; any change to insulin belongs with the treating physician.

Conclusion: This advice is false and dangerous: insulin must never be stopped on the basis of diet without medical supervision, because insulin omission is a leading cause of potentially fatal diabetic ketoacidosis.

Original statement
Scientific assessment
Scientific evidence in detail
In plain language
Studies on this claim
Regional context
What applies in my country?
References

Original statement

وقفي الانسولين عادي مش عايزين انسولين وهتخسي بقى وتبقي جميله والعبي رياضه عادي بقى ومرسي حياتك عادي وكلي سكر عادي وكلي بطاطس

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Advice given live to a viewer: stop insulin, it is not needed; eat sugar normally.

Origin

Source status: Video transcript (own words)
Attribution: Elawady (machine transcript)
Video: Dr.D Clinics - Diaa Al Awady is live! (Open source)
Published: 12 January 2025
Timestamp: 0:53:03 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty: Machine transcript of a live Q&A; the viewer's diabetes type and context are not known; in the same passage a viewer reports that her insulin-treated husband plans to stop insulin entirely and this is received approvingly.

Claimed mechanism: Diet makes insulin unnecessary.
Claimed health effect: Stopping insulin safely; weight loss.
Population concerned: People with diabetes using insulin
Geographic restriction by Elawady: none found

Diverging source versions

Source status: Video transcript (own words)
Attribution: Elawady (machine transcript)
Video: بدأت قناة ＂Dr Diaa Al Awady د ضياء العوضي＂ بثًا مباشرًاFAQs (Open source)
Published: 6 April 2026
Timestamp: not available (transcript has no timings)
Attribution uncertainty: Machine transcript; mentions a caller with high glucose, breathlessness and ketones (context of diabetic ketoacidosis).

Scientific assessment

False – The statement contradicts the robust evidence.

Certainty of evidence: high – Further research is very unlikely to change the assessment.

1. What was claimed?

Stop insulin; eat sugar normally.

2. What is demonstrably correct?

Lifestyle change can reduce medication needs in some people with type 2 diabetes, under medical supervision.

3. What is wrong or exaggerated?

Generalised advice to stop insulin without knowing the diabetes type, combined with eating sugar 'normally', can lead to dangerous hyperglycaemia and ketoacidosis. Sugar does raise blood glucose (C-SUG-04).

4. What remains unclear?

The full context of the individual viewer.

5. Which studies support it?

None.

6. Which studies contradict it?

I-INS-07 (consensus report: insulin omission a leading cause of DKA), I-ODD-16 and I-INS-10 (ADA Standards of Care 2026), I-SUG-07 and I-SUG-101 (sugar raises glucose and insulin).

7. What applies to Germany and Europe?

Not region-specific.

8. What is known about Egypt?

Not region-specific.

9. What practical conclusion is appropriate?

Never stop insulin without the treating physician.

Assessment details

Rationale for certainty of evidence: Stopping insulin in insulin-dependent diabetes (all type 1 and many type 2) can cause severe hyperglycaemia and diabetic ketoacidosis, which can be fatal. The ADA Standards of Care 2026 require insulin for most adults with type 1 diabetes (Rec. 9.1, grade A; I-ODD-16) and list missed insulin doses as a DKA precipitant (I-INS-10). The 2024 consensus report on hyperglycaemic crises (I-INS-07) identifies omission of insulin as one of the two most frequent causes of DKA (13-60% of cases by region) and reports 1-year mortality after DKA 13 times that of the general population. Any reduction of insulin must be supervised by the treating physician with glucose monitoring.
Source quality: Own words (machine transcript, live Q&A). Third-party list mytayibat.com also lists insulin among 'forbidden' items, whereas altayybat.com asks users not to stop prescribed medication.
Regional transferability: Universal.
Individual exceptions: Some people with type 2 diabetes can reduce or stop insulin under medical supervision after weight loss or lifestyle change; this requires monitoring.
Regional scope of the claim: general (biological/medical)
Last reviewed: 26 October 2026 provisional

Scientific evidence in detail

Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.

Research question: In people with insulin-treated diabetes, is stopping insulin while eating sugar 'normally' safe, or does it cause hyperglycaemia, diabetic ketoacidosis and death?

Research question in detail (PICO)

Population

People with insulin-treated diabetes (all type 1; insulin-requiring type 2)

Intervention or exposure

Stopping insulin and eating sugar without restriction

Comparison

Continued insulin therapy under medical supervision

Geographic scope

universal biology; health-system context matters for mortality (higher DKA mortality in low- and middle-income settings)

Outcomes

Diabetic ketoacidosis and hyperglycaemic crises
Mortality
Glycaemic control

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

Sugar in a meal acts like starch

Bantle JP et al.. N Engl J Med 1983 · PMID 6343873 · DOI 10.1056/NEJM198307073090102 Otherabstract checkednewly added

Small amounts of sucrose in a mixed meal raised blood glucose no more than starch in people with type 1 and type 2 diabetes; all type 1 participants remained on insulin.

Actual result
Sucrose meal did not produce greater peak glucose increments or AUC than potato, wheat or glucose meals in healthy, type 1 and type 2 groups.
Methodological quality
moderate for its narrow question (controlled single-meal study, 1983)
Relevance
indirect: supports only the narrow point that sugar within a planned meal can be covered by insulin; it gives no support for stopping insulin
Limitations
Single meals; small; participants on insulin.

Original publication
DiRECT: weight loss to put type 2 diabetes into remission

Lean ME et al.. Lancet 2018 · PMID 29221645 · DOI 10.1016/S0140-6736(17)33102-1 Randomised controlled trialabstract checked

In type 2 diabetes (not type 1), substantial weight loss under medical supervision achieved remission in some participants (DiRECT).

Actual result
Remission 46% vs 4% at 12 months; antidiabetic drugs withdrawn under supervision.
Methodological quality
high (cluster RCT)
Relevance
indirect: shows that some people with type 2 diabetes can reduce or stop medication through supervised weight loss, not by eating sugar normally
Limitations
Excluded insulin-treated patients; medication withdrawal was medically supervised.

Original publication

What speaks against the claim?

International guideline on diabetic ketoacidosis

Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032 Guideline / position statementfull text checked

International consensus report on hyperglycaemic crises identifies omission of insulin therapy as one of the two most frequent causes of DKA and describes high mortality.

Actual result
Insulin omission 13.3-59.6% of DKA precipitants by region; discontinuation of insulin >2/3 of DKA admissions in one cohort; 1-year mortality after DKA 13 times general population; inpatient DKA mortality up to 26-41% in some low- and middle-income settings.
Methodological quality
high (consensus based on systematic evidence review; guideline-level)
Relevance
direct
Limitations
Consensus document; mortality figures from observational data.

Original publication
ADA guideline 2026: diabetes medicines

American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care 2026 · PMID 41358900 · DOI 10.2337/dc26-S009 Guideline / position statementfull text checked

ADA Standards of Care 2026: most adults with type 1 diabetes must be treated with multiple daily insulin doses or insulin pumps (Rec. 9.1, grade A).

Actual result
Rec. 9.1 (A); Rec. 9.3 teaches matching insulin to carbohydrate intake.
Methodological quality
high (annually updated evidence-graded guideline)
Relevance
direct
Limitations
Guideline; recommendations for adults.

Original publication
ADA guideline 2026: blood sugar goals and emergencies

American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006 Guideline / position statementfull text checked

ADA Standards of Care 2026: hyperglycaemic crises are life-threatening; missed insulin doses are a precipitating factor requiring ketone monitoring.

Actual result
Ketone testing advised with illness, missed insulin doses or eating disorders, especially if glucose >200 mg/dL.
Methodological quality
high
Relevance
direct
Limitations
Guideline.

Original publication

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

Insulin must not be stopped without medical supervision; in type 1 diabetes insulin is life-sustaining. Eating sugar without adjusting insulin raises glucose further.

Why some studies weigh more

Guidelines and the consensus report rest on decades of clinical data and the established physiology of absolute insulin deficiency; the only 'supporting' items are indirect (supervised type 2 remission; sugar covered by insulin in a meal) and do not support the advice given.

Is a causal relationship established? Yes, established Insulin deficiency causes uncontrolled lipolysis and ketogenesis; insulin omission is a documented leading precipitant of DKA across regions, and DKA is lethal without treatment.

Remaining uncertainty

Individual context of the viewer (diabetes type, insulin reserve) is unknown; some people with type 2 diabetes can reduce insulin under supervision.

Justified conclusion

This advice is false and dangerous as general guidance: insulin must not be stopped on the basis of diet, and sugar does not make insulin unnecessary.

Why do studies seem to disagree?

No real conflict: DiRECT-type remission applies to selected people with type 2 diabetes losing weight under supervision, not to eating sugar normally or to type 1 diabetes.

Does this depend on the country?

General biological effects: Universal: absolute insulin deficiency in type 1 diabetes is not diet-dependent.
Eating habits: Diets high in sugar raise insulin needs.
Origin of the food: Not relevant.
Contaminants: Not relevant.
National production conditions: Not relevant.
Legal rules: Not relevant.
Actual monitoring data: Consensus report: insulin omission was 23.5% of DKA precipitants in Syria and up to 59.6% in the U.S.; DKA mortality is much higher where care is delayed.

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check

Range of insulin-omission share among DKA precipitants (Table 1 of consensus report) – 13.3% (Indonesia) to 59.6% (U.S. upper bound); read directly from the table, no recalculation needed not recalculable from the published data

Certainty of the overall evidence (GRADE, simplified)

Main outcome

DKA/hyperglycaemic crisis after stopping insulin in insulin-dependent diabetes

Starting level

low (observational studies)

Reasons for upgrading

very large effect (DKA is near-inevitable with absolute insulin deficiency)
established physiology

Result

high

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Clinical guidelines and official statements checked

ADA: 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (I-ODD-16) (2026) · Original publication
Rec. 9.1 (A): treat most adults with type 1 diabetes with continuous subcutaneous insulin infusion or multiple daily doses of prandial and basal insulin; 9.3: match mealtime insulin to carbohydrate intake.
ADA: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (I-INS-10) (2026) · Original publication
Hyperglycaemic crises are life-threatening and require immediate care; people at risk of DKA should measure ketones with symptoms and potential precipitating factors such as illness, missed insulin doses or eating disorders, particularly if glucose exceeds 200 mg/dL (11.1 mmol/L).
Consensus report published in Diabetes Care (Umpierrez GE et al.): Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (Diabetes Care 2024;47:1257-1275; I-INS-07) (2024) · Original publication
Most frequent causes of DKA/HHS are infection and omission of insulin therapy; insulin omission accounts for 13-60% of DKA precipitants across regions (Syria 23.5%, U.S. 41.0-59.6%); discontinuation of insulin accounted for more than two-thirds of DKA admissions in one urban cohort; after a DKA episode 1-year mortality is 13 times that of the general population; inpatient DKA mortality reaches 26-41% in some low- and middle-income settings.
ADA: 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026 (Diabetes Care 2026;49 Suppl 1:S89-S131; I-INTC-03) (2026) · Original publication
Rec. 5.14: minimise sugar-sweetened beverages, sweets, refined grains, processed and ultra-processed foods. Rec. 5.21: encourage water over other beverages (A). Rec. 5.22: nonnutritive sweeteners can replace sugar-sweetened products if consumed in moderation and for the short term (B). Rec. 5.25: replace sugar-sweetened beverages (including any juices) with water or low/no-calorie beverages and minimise foods with added sugar (B).

Search strategy

Documented literature searches for this review (search strings in the original database syntax).

Database	Date	Search	Looking for	Hits
Europe PMC	26 October 2026	`TITLE:"hyperglycemic crises" AND (consensus OR guideline) AND PUB_YEAR:[2023 TO 2026]`	guidelines	11
Europe PMC	26 October 2026	`"Standards of Care in Diabetes-2026"`	guidelines	41
Europe PMC	26 October 2026	`(TITLE:"insulin omission" OR TITLE:"discontinuation of insulin" OR TITLE:"stopped insulin") AND (ketoacidosis OR mortality)`	contradicting evidence	9
Europe PMC	26 October 2026	`(Egypt OR Egyptian) AND ("diabetic ketoacidosis") AND ("insulin omission" OR "missed insulin" OR "precipitating")`	contradicting evidence	144
Europe PMC	26 October 2026	`("diabetic ketoacidosis") AND ("alternative medicine" OR "herbal" OR "traditional healer" OR "diet") AND ("stopped insulin" OR "discontinued insulin" OR "insulin cessation" OR "cessation of insulin")`	supporting evidence	123
Europe PMC	26 October 2026	`TITLE:("type 1 diabetes") AND ("insulin" ) AND TITLE:("without insulin" OR "insulin-free" OR "discontinue insulin" OR "stop insulin") AND (diet)`	supporting evidence	2
PubMed	26 October 2026	`(insulin omission[tiab] OR insulin discontinuation[tiab] OR missed insulin[tiab]) AND diabetic ketoacidosis[tiab] AND (cohort[tiab] OR systematic review[pt] OR consensus[tiab])`	contradicting evidence	6
PubMed	26 October 2026	`(type 1 diabetes[ti]) AND (insulin withdrawal[tiab] OR without insulin[tiab]) AND (sucrose[tiab] OR sugar[tiab] OR diet[tiab]) AND (remission[tiab] OR survival[tiab])`	supporting evidence	15
PubMed	26 October 2026	`Bantle JP[au] AND sucrose AND postprandial`	both directions	5
PMC (ADA Standards of Care 2026, sections 5, 6, 9; consensus report)	26 October 2026	`Full-text pages PMC12690188, PMC12690178, PMC12690185, PMC11272983 fetched and searched for insulin omission, type 1 treatment and sugar recommendations`	guidelines	1

Open questions

None that would change the verdict.

How deeply was this checked?

6 linked studies: 3 checked in full text (0 of them with a structured risk-of-bias assessment), 3 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict

25 October 2026 · Phase 1 · Initial assessment: False (high)
26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: False (high)
Guidelines fetched today (ADA 2026 sections 6 and 9; 2024 consensus report) confirm the existing verdict. The safety note is kept and sharpened.
New sources: I-SUG-102

In plain language

In a live video, Dr. Diaa told a viewer to stop insulin and eat sugar normally. Stopping insulin can be life-threatening for people whose bodies do not make enough of it, for example in type 1 diabetes. Some people with type 2 diabetes can reduce insulin after lifestyle changes, but only with medical supervision and glucose checks.

Studies on this claim

Studies supporting the claim (1)

DiRECT: weight loss to put type 2 diabetes into remission

Lean ME et al.. Lancet 2018 · PMID 29221645 · DOI 10.1016/S0140-6736(17)33102-1

Randomised controlled trialindependent cross-checkabstract checked★ key study

46% of people in the programme were free of diabetes and medication after one year.

Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

Original publication · Scientific details

Study explained simply
What did the researchers want to find out?
Can intensive weight management in primary care achieve T2D remission?
How was the study done?
Open-label cluster-randomised trial (DiRECT)
How many people, animals or samples were studied?
306 (149 per group ITT); 49 practices; Age 20-65, T2D <6 years, BMI 27-45, not on insulin
What was actually found?
Remission 46% vs 4%.
How large was the observed effect?
OR 19.7
What do the results mean in everyday life?
Losing 10-15 kg can reverse early type 2 diabetes.
What are the study's limitations?
Open-label; Selected population; Formula diet
What does it say about Elawady's specific claim?
Supports C-DIAB-03 (with conditions); limited relevance to C-INS-10 (insulin users excluded).
Do the results apply to Germany and Europe?
UK; directly relevant.
What can explicitly not be concluded from this study?
Effect of the Tayebat diet; effect in type 1 or insulin-treated diabetes.
Scientific details →

Studies contradicting or limiting the claim (4)

Sugar cola vs diet cola vs sparkling water: blood sugar and insulin

Galicia-Ayala C et al.. Nutrition 2026 · PMID 41016269 · DOI 10.1016/j.nut.2025.112938

Randomised controlled trialindependent cross-checkabstract checked

Sugar-sweetened cola raised blood sugar and insulin most; diet cola and sparkling water did not.

Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

Original publication · Scientific details

Study explained simply
What did the researchers want to find out?
Acute glucose and hormone responses to sucrose vs NNS colas.
How was the study done?
Randomized crossover trial, 4 beverages, 7-day washout.
How many people, animals or samples were studied?
20; Healthy adults
What was actually found?
Sucrose beverage elicited the highest glucose and insulin responses with significant increases at 30 min (P<0.001); aspartame/acesulfame-K and carbonated water showed no significant differences in glucose or hormones.
How large was the observed effect?
Significant rise at 30 min
What do the results mean in everyday life?
Sugar raises insulin in healthy people.
What are the study's limitations?
Small; Acute only
What does it say about Elawady's specific claim?
Contradicts C-SUG-04 and C-SUG-07; context for C-SOD-13 (carbonated water had no hormonal effect).
Do the results apply to Germany and Europe?
High (physiology).
What can explicitly not be concluded from this study?
Long-term effects.
Scientific details →
International guideline on diabetic ketoacidosis

Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032

Guideline / position statementindependent cross-checkfull text checked★ key study

Insulin, fluids and potassium are the core treatment; with this, fewer than 1% of adults die.

Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

Original publication · Scientific details

Study explained simply
What did the researchers want to find out?
Diagnosis and management of DKA and HHS in adults
How was the study done?
International consensus report based on systematic examination of literature since 2009 (ADA, EASD, JBDS, AACE, DTS)
How many people, animals or samples were studied?
not applicable; Adults with diabetes
What was actually found?
Insulin is the cornerstone; glucocorticoids worsen hyperglycaemia.
How large was the observed effect?
Mortality <1% with treatment
What do the results mean in everyday life?
Ketoacidosis needs hospital treatment with insulin.
What are the study's limitations?
Consensus, not trial
What does it say about Elawady's specific claim?
Directly contradicts C-INS-08; supports danger in C-FAST-03; contradicts C-INS-07, C-INS-10.
Do the results apply to Germany and Europe?
EASD and JBDS (UK) co-authored; directly applicable.
What can explicitly not be concluded from this study?
Outcomes of untreated DKA quantitatively.
Scientific details →
ADA guideline 2026: diabetes medicines

American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care 2026 · PMID 41358900 · DOI 10.2337/dc26-S009

Guideline / position statementindependent cross-checkfull text checked★ key study

Insulin is essential in type 1 diabetes; SGLT2/GLP-1 drugs are recommended for heart and kidney protection; side effects listed.

Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

Original publication · Scientific details

Study explained simply
What did the researchers want to find out?
Pharmacologic glycaemic treatment
How was the study done?
Clinical practice guideline (ADA Standards of Care 2026, Section 9)
How many people, animals or samples were studied?
not applicable; People with type 1 and type 2 diabetes
What was actually found?
See results.
How large was the observed effect?
not applicable
What do the results mean in everyday life?
Medicines chosen by benefit-risk.
What are the study's limitations?
Partially read
What does it say about Elawady's specific claim?
Contradicts C-INS-07, C-INS-10, C-ODD-06; supports C-ODD-07, C-INS-11.
Do the results apply to Germany and Europe?
Consistent with ADA/EASD consensus.
What can explicitly not be concluded from this study?
Not applicable.
Scientific details →
ADA guideline 2026: blood sugar goals and emergencies

American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006

Guideline / position statementindependent cross-checkfull text checked★ key study

Most adults should aim for HbA1c below 7%, avoid low sugar, and measure ketones when at risk.

Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

Original publication · Scientific details

Study explained simply
What did the researchers want to find out?
Glycaemic goals, hypoglycaemia and hyperglycaemic crises
How was the study done?
Clinical practice guideline (ADA Standards of Care 2026, Section 6)
How many people, animals or samples were studied?
not applicable; People with diabetes
What was actually found?
Individual targets; do not stop basal insulin when not eating.
How large was the observed effect?
not applicable
What do the results mean in everyday life?
Moderate targets and safety rules.
What are the study's limitations?
US-centred; Partially read
What does it say about Elawady's specific claim?
Supports C-INS-04, C-INS-11; contradicts C-FAST-01, C-FAST-03, C-DIAB-02.
Do the results apply to Germany and Europe?
Consistent with EASD guidance.
What can explicitly not be concluded from this study?
Not applicable.
Scientific details →

Studies with mixed or unclear results (1)

Sugar in a meal acts like starch

Bantle JP et al.. N Engl J Med 1983 · PMID 6343873 · DOI 10.1056/NEJM198307073090102

Otherindependent cross-checkabstract checked

In 1983, meals containing table sugar raised blood sugar about as much as meals with potato or wheat starch, in healthy people and people with diabetes.

Small amounts of sucrose in meals behaved like starch, but all type 1 participants were on insulin; nothing supports stopping insulin.

Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

Original publication · Scientific details

Study explained simply
What did the researchers want to find out?
Test whether the type of carbohydrate changes blood sugar and insulin after a meal.
How was the study done?
Participants ate five meals that differed only in the type of carbohydrate.
How many people, animals or samples were studied?
10 healthy adults, 12 with type 1 and 10 with type 2 diabetes.
What was actually found?
Sucrose meals did not raise blood sugar more than starch meals; insulin peaks were similar.
How large was the observed effect?
No significant differences between sucrose and starch meals.
What do the results mean in everyday life?
A small amount of sugar inside a balanced meal is handled like other carbohydrates.
What are the study's limitations?
Short single-meal tests; old study; small groups.
What does it say about Elawady's specific claim?
Supports including some sugar in a meal plan; gives no support for stopping insulin.
Do the results apply to Germany and Europe?
Physiology applies in Europe and Egypt.
What can explicitly not be concluded from this study?
Cannot show that large sugar intakes or stopping insulin are safe.
Scientific details →

Regional context

Germany / EU

Not region-specific.

Egypt

Not region-specific.

What applies in my country?

General scientific assessment

False This advice is false and dangerous: insulin must never be stopped on the basis of diet without medical supervision, because insulin omission is a leading cause of potentially fatal diabetic ketoacidosis.

The following areas of food safety are relevant to this statement:

Additives and processing

Honey, sugar, sweets

Choose a country to see the checked information for it.

Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.

Country of residence or purchase Compare with another country

References

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.. Lean ME et al.. Lancet 2018 · PMID 29221645 · DOI 10.1016/S0140-6736(17)33102-1
Enteroendocrine hormonal response after the ingestion of cola beverages with sucrose and non-nutritive sweeteners in healthy adults: A randomized crossover trial.. Galicia-Ayala C et al.. Nutrition 2026 · PMID 41016269 · DOI 10.1016/j.nut.2025.112938
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.. Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care 2026 · PMID 41358900 · DOI 10.2337/dc26-S009
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006
Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects.. Bantle JP et al.. N Engl J Med 1983 · PMID 6343873 · DOI 10.1056/NEJM198307073090102

← Back to overview

Advice given live to a viewer: stop insulin, it is not needed; eat sugar normally.

Original statement

Translation

Origin

Diverging source versions

Scientific assessment

1. What was claimed?

2. What is demonstrably correct?

3. What is wrong or exaggerated?

4. What remains unclear?

5. Which studies support it?

6. Which studies contradict it?

7. What applies to Germany and Europe?

8. What is known about Egypt?

9. What practical conclusion is appropriate?

Assessment details

Scientific evidence in detail

What speaks for the claim?

Sugar in a meal acts like starch

DiRECT: weight loss to put type 2 diabetes into remission

What speaks against the claim?

International guideline on diabetic ketoacidosis

ADA guideline 2026: diabetes medicines

ADA guideline 2026: blood sugar goals and emergencies

What does the overall evidence say?

Which position is better supported?

Why some studies weigh more

Remaining uncertainty

Justified conclusion

Open questions

How deeply was this checked?

In plain language

Studies on this claim

Studies supporting the claim (1)

DiRECT: weight loss to put type 2 diabetes into remission

Studies contradicting or limiting the claim (4)

Sugar cola vs diet cola vs sparkling water: blood sugar and insulin

International guideline on diabetic ketoacidosis

ADA guideline 2026: diabetes medicines

ADA guideline 2026: blood sugar goals and emergencies

Studies with mixed or unclear results (1)

Sugar in a meal acts like starch

Regional context

Germany / EU

Egypt

What applies in my country?

General scientific assessment

References